TAILORx study finds early, abrupt cognitive decline among patients with breast cancer
Click on the article title to read more.
Related Articles
Efficacy and safety of nanoparticle albumin‐bound paclitaxel in taxane‐pretreated metastatic breast cancer patients
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) improved the median progression-free survival with tolerable side effects in metastatic breast cancer patients previously treated with taxanes, …
Real‐world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis
Endocrine backbone therapy demonstrated good efficacy among patients with hormone receptor-positive/HER2-negative metastatic breast cancer who received subsequent treatment after progression on palbo…
Top advances of the year: Gastroesophageal cancer
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study
For patients with breast cancer with initial bone metastasis, clinicians can use this nomogram based on population studies to assess whether patients can benefit from…
The impact of outpatient supportive oncology on cancer care cost and utilization
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Top advances of the year: Cervical cancer
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.